Craft
  • Home
  •  / Gossamer Bio
Gossamer Bio

Gossamer Bio

Market Capitalization

$939 M

2022-09-22

Gossamer Bio Summary

Company summary

Overview
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Its strategy is to leverage an asset-rich in-licensing environment, with a focus on utilizing a team with a track record of execution in immunology, inflammation, fibrosis and oncology.
Type
Public
Founded
2015
HQ
San Diego, CA, US | view all locations
Website
http://gossamerbio.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Bryan Giraudo

    Bryan Giraudo, Chief Financial Officer

    • Luisa Salter-Cid

      Luisa Salter-Cid, Chief Scientific Officer

      • Kristina Burow

        Kristina Burow, Director

        • Thomas Daniel

          Thomas Daniel, Director

          LocationsView all

          2 locations detected

          • San Diego, CA HQ

            United States

            3013 Science Park Rd #200

          • Dublin 2, County Dublin

            Ireland

            Fitzwilliam Hall, Glandore Business Centres, Fitzwilliam Pl

          Gossamer Bio Financials

          Summary financials

          Net income (Q2, 2022)
          ($56.5M)
          Cash (Q2, 2022)
          $94.3M
          EBIT (Q2, 2022)
          ($53.9M)
          Enterprise value
          $873.9M

          Footer menu